Ensysce Biosciences Inc. Gains 49.17%
Tue, Aug 27, 2024 at 07:50 PM
Ensysce Biosciences Inc. (ENSC:NASDAQ) shot up at $0.64, representing a gain of 49.2%. On Tue, Aug 27, 2024, ENSC:NASDAQ hit a New 2-Week High of $0.64. The stock appeared on our News Catalysts scanner on Tue, Aug 27, 2024 at 03:57 PM in the 'MISCELLANEOUS' category. From Tue, Aug 13, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Aug 27, 2024 at $0.81 with a volume of 94M+.
About Ensysce Biosciences Inc. (ENSC:NASDAQ)
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.
Top 10 Gainers:
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 150%
- BOQI International Medical Inc. (BIMI:NASDAQ), 90.48%
- VOXX International Corporation (VOXX:NASDAQ), 68.07%
- Santech Holdings Ltd ADS (STEC:NASDAQ), 58.03%
- Addex Therapeutics Ltd (ADXN:NASDAQ), 54.61%
- LightInTheBox Holding Co., Ltd. (LITB:NYSE), 49.93%
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 49.17%
- Brera Holdings PLC (BREA:NASDAQ), 35.73%
- Meihua International Medical Technologies Co. Ltd. (MHUA:NASDAQ), 33.33%
- One Stop Systems, Inc. (OSS:NASDAQ), 25.85%